Elzbieta Bylina

Warsaw, MZ 00801, Poland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Medical research agency: 5 years of reshaping the clinical trials ecosystem in Poland.

Medical research agency: 5 years of reshaping the clinical trials ecosystem in Poland.

Journal: The Lancet regional health. Europe
Published: November 26, 2024

From Molecular Biology to Novel Immunotherapies and Nanomedicine in Uveal Melanoma.

From Molecular Biology to Novel Immunotherapies and Nanomedicine in Uveal Melanoma.

Journal: Current oncology (Toronto, Ont.)
Published: October 10, 2023

Interpretable artificial intelligence to optimise use of imatinib after resection in patients with localised gastrointestinal stromal tumours: an observational cohort study.

Interpretable artificial intelligence to optimise use of imatinib after resection in patients with localised gastrointestinal stromal tumours: an observational cohort study.

Journal: The Lancet. Oncology
Published: August 22, 2023

An interpretable AI model for recurrence prediction after surgery in gastrointestinal stromal tumour: an observational cohort study.

An interpretable AI model for recurrence prediction after surgery in gastrointestinal stromal tumour: an observational cohort study.

Journal: EClinicalMedicine
Published: June 20, 2023

Treatment of Gastrointestinal Stromal Tumors (GISTs): A Focus on Younger Patients.

Treatment of Gastrointestinal Stromal Tumors (GISTs): A Focus on Younger Patients.

Journal: Cancers
Published: May 21, 2022

Merkel Cell Carcinoma from Molecular Pathology to Novel Therapies.

Merkel Cell Carcinoma from Molecular Pathology to Novel Therapies.

Journal: International journal of molecular sciences
Published: April 26, 2021

Chondrosarcoma-from Molecular Pathology to Novel Therapies.

Chondrosarcoma-from Molecular Pathology to Novel Therapies.

Journal: Cancers
Published: April 18, 2021

Treatment of Metastatic Gastrointestinal Stromal Tumors (GIST): A Focus on Older Patients.

Treatment of Metastatic Gastrointestinal Stromal Tumors (GIST): A Focus on Older Patients.

Journal: Drugs & aging
Published: February 01, 2021

The analysis of 3-year adjuvant therapy with imatinib in patients with high-risk molecular profiled gastrointestinal stromal tumors (GIST) treated in routine practice.

The analysis of 3-year adjuvant therapy with imatinib in patients with high-risk molecular profiled gastrointestinal stromal tumors (GIST) treated in routine practice.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: June 07, 2020

Quality of treatment and surgical approach for rectal gastrointestinal stromal tumour (GIST) in a large European cohort.

Quality of treatment and surgical approach for rectal gastrointestinal stromal tumour (GIST) in a large European cohort.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: January 14, 2020

Prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in patients with advanced gastrointestinal stromal tumors treated with sunitinib after imatinib failure.

Prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in patients with advanced gastrointestinal stromal tumors treated with sunitinib after imatinib failure.

Journal: Oncology letters
Published: March 27, 2019

Blood neutrophil-to-lymphocyte ratio is associated with prognosis in advanced gastrointestinal stromal tumors treated with imatinib.

Blood neutrophil-to-lymphocyte ratio is associated with prognosis in advanced gastrointestinal stromal tumors treated with imatinib.

Journal: Tumori
Published: May 02, 2018
Showing 1-12 of 22

Last Updated: 09/26/2026